FloraGLO Lutein Z (Tagetes erecta)
FloraGLO Lutein Z is a patented lutein extract from Tagetes erecta that increases serum lutein levels 2.4-fold at 6 mg daily. It accumulates in macular tissue as an antioxidant carotenoid pigment to potentially protect against blue light damage.

Origin & History
FloraGLO Lutein is a branded, unesterified (free) form of lutein derived from marigold flowers (Tagetes erecta), native to Mexico and Central America. It is produced via solvent extraction of marigold flowers to yield an oleoresin (~70% lutein), followed by further purification to crystalline form containing ≥80% total carotenoids (76% lutein, 7% zeaxanthin).
Historical & Cultural Context
No historical or traditional medicine uses for FloraGLO Lutein or Tagetes erecta lutein are documented in the research. Modern commercial extraction focuses solely on nutraceutical and food coloring applications (EU E161b, GRAS status).
Health Benefits
• Increases serum lutein levels 2.4-fold at 6 mg/day dose (bioavailability study evidence) • May protect macular tissue from phototoxic damage as an antioxidant pigment (mechanistic evidence only) • Accumulates in the fovea periphery to support eye health (general lutein evidence, not FloraGLO-specific) • Quenches reactive oxygen species in ocular tissues (theoretical mechanism, no clinical trials) • Comparable bioavailability to lutein esters (comparative study evidence)
How It Works
FloraGLO Lutein functions as a macular pigment that selectively accumulates in the fovea and surrounding retinal tissue. It acts as an antioxidant by quenching singlet oxygen and filtering high-energy blue light wavelengths (400-500nm) that can cause photochemical damage to retinal cells.
Scientific Research
Clinical evidence specific to FloraGLO Lutein is limited to one bioavailability study comparing free lutein capsules (6 mg/day) to lutein esters, showing 2.4-fold serum lutein increases. No PMIDs, sample sizes, or vision/brain outcome studies for FloraGLO were available in the research; broader lutein evidence was referenced indirectly.
Clinical Summary
Bioavailability studies demonstrate that 6 mg daily FloraGLO Lutein increases serum lutein concentrations 2.4-fold compared to baseline. The lutein specifically accumulates in foveal periphery tissue based on general lutein research, though FloraGLO-specific macular studies are limited. Evidence for macular protection remains primarily mechanistic, with human clinical outcomes for this specific extract requiring further investigation.
Nutritional Profile
FloraGLO Lutein Z is a standardized, purified extract from Tagetes erecta (marigold) oleoresin, not a whole food, so macronutrient content (protein, fat, carbohydrate, fiber) is negligible at typical dosing. **Primary bioactive compounds:** • Free (unesterified) lutein: standardized typically at 5–20% w/w in commercial raw material; common supplement doses deliver 6–20 mg lutein per serving • Zeaxanthin (primarily trans-zeaxanthin): present as a minor co-pigment, typically at approximately 0.3–1 mg per 6 mg lutein dose (lutein-to-zeaxanthin ratio roughly 5:1 to 10:1, reflecting the natural marigold carotenoid profile) • Trace carotenoids: minor amounts of β-carotene and other xanthophylls (<0.1 mg per dose). **Lipid matrix:** The oleoresin carrier contains residual triglycerides, fatty acid esters, and waxes from marigold petals; commercial beadlet/softgel forms often incorporate medium-chain triglycerides, sunflower oil, or safflower oil to enhance solubility. **Vitamins & minerals:** No significant vitamin or mineral content intrinsic to the extract at supplemental doses. **Bioavailability notes:** FloraGLO uses the free (non-esterified) crystalline form of lutein, which does not require intestinal esterase hydrolysis prior to absorption, distinguishing it from esterified lutein sources. Oral bioavailability is fat-dependent; co-ingestion with ≥3–5 g dietary fat significantly enhances absorption. A pharmacokinetic study demonstrated a 2.4-fold increase in serum lutein from a 6 mg/day dose over baseline. Lutein is absorbed via passive diffusion in the small intestine, incorporated into chylomicrons, transported via lipoproteins (primarily HDL), and selectively accumulated in the macula lutea of the retina. The meso-zeaxanthin isomer can be formed in vivo from lutein within retinal tissue. Steady-state serum levels are typically reached within 2–4 weeks of consistent daily dosing. No significant interactions with other fat-soluble vitamins reported, though high-dose β-carotene may competitively reduce lutein absorption.
Preparation & Dosage
Clinically studied doses include 6 mg/day of FloraGLO Lutein (10% dispersion in capsules). General marigold lutein studies use 5-15 mg/day. Products are typically standardized to 10% lutein dispersion or crystalline form with ≥74-80% total carotenoids. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
zeaxanthin, astaxanthin, bilberry extract, vitamin E, omega-3 fatty acids
Safety & Interactions
FloraGLO Lutein is generally well-tolerated with no significant adverse effects reported in clinical studies. It may theoretically enhance absorption of fat-soluble vitamins when taken together due to shared absorption pathways. No known drug interactions have been documented, though it should be taken with dietary fat for optimal absorption. Safety during pregnancy and lactation has not been specifically established for this patented extract.